spacer
home > ebr > summer 2017 > strategic advantage
PUBLICATIONS
European Biopharmaceutical Review

Strategic Advantage

Pharmacovigilance (PV) is beginning to touch more aspects of life sciences organisations in the form of additional functions as well as international operations, including affiliates. Overcoming silos and establishing closer collaboration between PV and quality operations is a growing priority and, as circumstances evolve, responsibility for the monitoring of safety and associated systems will have to be shared by an increasingly diverse range of stakeholders.

Quality Rules


One thing the life sciences industry cannot escape is a heightened emphasis on quality as inspections increase. Although this presents certain obstacles, it also prompts companies to put better systems and processes in place senior management now understands the importance of PV and are beginning to allocate more resources to it.

The conceivable downside is that too much attention on compliance could detract from the real motivation underlying all of this which is, of course, to improve patient safety and public confidence. Two ways of keeping things in clear focus are to get teams working together more readily and to take shared responsibility for making improvements.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Cheryl Key, MBBS, MFPM, is Head of Practice PV Platform Services and Principal Medic at ProductLife Group, with final responsibility for all projects, programmes and engagements in the platform, as well as for day-to-day management of the platform team. She has a medical degree from Charing Cross and Westminster Medical School, UK, a diploma in pharmaceutical medicine, membership of the Royal College of General Practitioners and membership of the Faculty of Pharmaceutical Medicine. Cheryl is also on the Specialist Register at the General Medical Council for Pharmaceutical Medicine and a member of the board of the Faculty of Pharmaceutical Medicine.
spacer
Cheryl Key
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Edinburgh, UK September 20th, 2017 - Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
More info >>

White Papers

Modular Feeding Systems for Prefilled Syringes and Injection Devices

Dividella

The pre-filled syringe and injection device is an increasingly attractive presentation for both new and established parenteral pharmaceuticals. We will explore how innovative carton packaging solutions can enhance this presentation whilst meeting the stringent requirements of product protection.
More info >>

 
Industry Events

3D Cell Culture 2018

21-22 February 2018, Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement